Emma Guttman

Dupilumab in the Treatment of Pediatric Alopecia Areata

National Institute of Allergy and Infectious Diseases · U01

Contact PI · $4M · Icahn School of Medicine at Mount Sinai

Use of Specific JAK Inhibition on Inflammatory Skin and Scalp Diseases in Down Syndrome

National Institute of Arthritis and Musculoskeletal and Skin Diseases · R33

Contact PI · $1.4M · Icahn School of Medicine at Mount Sinai

Biomarkers of Atopy Beginning Early (BABE)

National Institute of Allergy and Infectious Diseases · U19

Project lead · $1.1M · University of Rochester

Developing a Molecular Map of Atopic Dermatitis Across Ethnicity and Severity Subtypes.

National Institute of Allergy and Infectious Diseases · U01

Contact PI · $2.1M · Icahn School of Medicine at Mount Sinai

Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome

Principal investigator · Recruiting · Phase 2

Icahn School of Medicine at Mount Sinai

Ritlecitinib in Patients With Keloids or Those Undergoing Keloidectomy

Principal investigator · Recruiting · Phase 2

Icahn School of Medicine at Mount Sinai

Dupilumab in the Treatment of Pediatric Alopecia Areata

Principal investigator · Recruiting · Phase 2

Icahn School of Medicine at Mount Sinai

Regeneron AA Multicenter (Dupilumab)

Principal investigator · Recruiting · Phase 2

Emma Guttman